查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1800211

全球重症加护诊断市场：2025 年至 2030 年预测

Global Critical Care Diagnostics Market - Forecasts fom 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 151 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

重症加护诊断市场预计将从 2025 年的 1,665,035,000 美元成长到 2030 年的 2,244,484,000 美元，复合年增长率为 6.15%。

预计重症加护诊断市场将在2025年至2030年间强劲成长，这得益于严重和末期病患对快速精准诊断解决方案日益增长的需求。这些诊断包括癌症生物标记筛检、心臟标记诊断、药物滥用检测、病原体筛检和胆固醇检测等，使医生能够快速诊断疾病并及时启动治疗。儘管慢性病盛行率上升和先进诊断技术日益普及推动了市场的发展，但设备成本上升和熟练专业人员短缺等挑战可能阻碍市场的发展。

市场驱动因素

重症加护诊断市场受慢性疾病（尤其是心臟疾病和癌症）盛行率上升的驱动。这些疾病的全球负担推动了对能够提供快速准确结果的检测的需求，使医生能够及时做出明智的治疗决策。此外，医疗保健专业人员越来越多地采用重症加护诊断也是一个主要的成长要素。这些诊断由侵入式和非侵入式监测设备支持，在加护治疗环境中变得越来越重要，因为准确性和速度至关重要。诊断平台的技术进步进一步提高了可靠性和可近性，从而进一步推动了市场扩张。

市场限制

儘管重症加护诊断市场拥有成长潜力，但也面临显着挑战。分子检测平台和影像系统等先进诊断设备价格高昂，可能会限制其普及，尤其是在资源匮乏的医疗环境中。此外，缺乏熟练操作复杂诊断系统和解读结果的专业人员，也构成了重大障碍，尤其是在开发中地区。除非透过经济高效的创新和强化培训项目来解决这些限制因素，否则市场成长可能会受到阻碍。

目录

第一章执行摘要

第二章市场概述

  • 市场概览
  • 市场定义
  • 调查范围
  • 市场区隔

第三章 经营状况

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策法规
  • 策略建议

第四章 技术展望

第五章全球重症加护诊断市场（按类型）

  • 介绍
  • 血液学
  • 心臟和脂质检测
  • 血液凝固检验
  • 微生物学和传染病检查
  • 其他的

第六章全球重症加护诊断市场（依最终用户）

  • 介绍
  • 医院
  • 诊断中心
  • 居家照护
  • 其他的

第七章全球重症加护诊断市场（按地区）

  • 介绍
  • 北美洲
    • 按类型
    • 按用途
    • 按国家
      • 美国
      • 加拿大
      • 墨西哥
  • 南美洲
    • 按类型
    • 按用途
    • 按国家
      • 巴西
      • 阿根廷
      • 其他的
  • 欧洲
    • 按类型
    • 按用途
    • 按国家
      • 德国
      • 法国
      • 英国
      • 西班牙
      • 其他的
  • 中东和非洲
    • 按类型
    • 按用途
    • 按国家
      • 沙乌地阿拉伯
      • 阿拉伯聯合大公国
      • 以色列
      • 其他的
  • 亚太地区
    • 按类型
    • 按用途
    • 按国家
      • 中国
      • 印度
      • 日本
      • 韩国
      • 印尼
      • 泰国
      • 其他的

第八章竞争格局及分析

  • 主要企业和策略分析
  • 市场占有率分析
  • 合併、收购、协议和合作
  • 竞争对手仪表板

第九章：公司简介

  • Abbott Laboratories
  • bioMerieux SA
  • Danaher Corporation
  • Radiometer Medical ApS
  • Trivitron Healthcare
  • Siemens Healthcare GmbH
  • Becton Dickinson Company
  • Bayer AG
  • Roche Diagnostics
  • Bio-Rad Laboratories, Inc.

第十章 附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要利益
  • 调查方法
  • 简称
简介目录
Product Code: KSI061611691

The global critical care diagnostics market is expected to grow from USD1,665.035 million in 2025 to USD2,244.484 million in 2030, at a CAGR of 6.15%.

The critical care diagnostics market is poised for robust growth from 2025 to 2030, driven by the increasing need for rapid and accurate diagnostic solutions for critically ill or terminally ill patients with life-threatening conditions. These diagnostics, encompassing tests such as cancer biomarker screening, cardiac marker diagnostics, drug abuse testing, pathogen screening, and cholesterol testing, enable physicians to diagnose diseases swiftly and initiate timely treatment. The market is propelled by the rising prevalence of chronic diseases and the growing adoption of advanced diagnostic technologies, though challenges like high equipment costs and a shortage of skilled professionals may impede progress.

Market Drivers

The critical care diagnostics market is primarily driven by the rising incidence of chronic diseases, notably cardiac conditions and cancer, which require sophisticated diagnostic tools for effective management. The global burden of these diseases has increased demand for tests that provide rapid and precise results, enabling physicians to make informed treatment decisions without delay. Additionally, the growing adoption of critical care diagnostics by healthcare professionals is a significant growth factor. These diagnostics, supported by invasive and non-invasive monitoring devices, are increasingly integral to intensive care settings, where accuracy and speed are paramount. Technological advancements in diagnostic platforms further enhance their reliability and accessibility, boosting market expansion.

Market Restraints

Despite its growth potential, the critical care diagnostics market faces notable challenges. The high cost of advanced diagnostic equipment, such as molecular testing platforms and imaging systems, can limit adoption, particularly in resource-constrained healthcare settings. Additionally, a shortage of skilled professionals trained to operate complex diagnostic systems and interpret results poses a significant barrier, especially in developing regions. These constraints may hinder market growth unless addressed through cost-effective innovations and enhanced training programs.

Market Segmentation

By Application

The critical care diagnostics market is segmented into hematology, cardiac and lipid testing, coagulation testing, microbial and infectious disease testing, and others. Cardiac and lipid testing holds a significant share due to the high prevalence of cardiovascular diseases, necessitating rapid biomarker diagnostics. Microbial and infectious disease testing is also growing, driven by the need for early detection of pathogens in critical care settings. Hematology and coagulation testing remain vital for managing blood-related disorders, while other applications, such as cancer biomarker testing, are gaining traction due to rising cancer rates.

By End Users

The market is segmented into diagnostic centers, research laboratories, home care settings, and others. Diagnostic centers dominate due to their advanced infrastructure and capacity to handle high-throughput testing for critically ill patients. Research laboratories contribute to market growth through the development of novel diagnostic technologies. Home care settings are emerging as a growing segment, driven by the increasing availability of portable diagnostic devices, which enable monitoring and testing outside traditional healthcare facilities.

By Geography

The global critical care diagnostics market is segmented into North America, South America, Europe, the Middle East and Africa (MEA), and Asia-Pacific. North America leads due to its advanced healthcare infrastructure, high adoption of cutting-edge diagnostics, and significant prevalence of chronic diseases. Europe follows closely, supported by robust research and development activities. The Asia-Pacific region is expected to witness rapid growth, driven by increasing healthcare investments and rising disease burdens in countries like China and India. South America and MEA are also projected to grow, supported by improving healthcare access and awareness.

Key Industry Players

Major players in the critical care diagnostics market include companies focused on developing innovative diagnostic solutions. These players are investing in research, strategic partnerships, and product launches to strengthen their market positions. The report highlights their competitive strategies, financial performance, and recent developments, emphasizing their role in advancing diagnostic technologies.

The critical care diagnostics market is set for significant growth from 2025 to 2030, driven by the rising prevalence of chronic diseases and the adoption of advanced diagnostic tools. While high costs and a shortage of skilled professionals present challenges, the market's outlook remains positive, particularly in North America, Europe, and Asia-Pacific. Industry players must focus on affordability, training, and technological innovation to capitalize on the growing demand for rapid and accurate diagnostics in critical care settings.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2020 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Global Critical Care Diagnostics Market Segmentation

By Type

  • Haematology
  • Cardiac and Lipid Testing
  • Coagulation Testing
  • Microbial and Infectious Disease Testing
  • Others

By End-User

  • Hospitals
  • Diagnostics Centers
  • Home Care Setting
  • Others

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. Haematology
  • 5.3. Cardiac and lipid Testing
  • 5.4. Coagulation Testing
  • 5.5. Microbial and Infectious Disease Testing
  • 5.6. Others

6. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY END-USER

  • 6.1. Introduction
  • 6.2. Hospitals
  • 6.3. Diagnostics Centers
  • 6.4. Home Care Settings
  • 6.5. Others

7. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY GEOGRAPHY

  • 7.1. Introduction
  • 7.2. North America
    • 7.2.1. ByType
    • 7.2.2. By Application
    • 7.2.3. By Country
      • 7.2.3.1. USA
      • 7.2.3.2. Canada
      • 7.2.3.3. Mexico
  • 7.3. South America
    • 7.3.1. By Type
    • 7.3.2. By Application
    • 7.3.3. By Country
      • 7.3.3.1. Brazil
      • 7.3.3.2. Argentina
      • 7.3.3.3. Others
  • 7.4. Europe
    • 7.4.1. By Type
    • 7.4.2. By Application
    • 7.4.3. By Country
      • 7.4.3.1. Germany
      • 7.4.3.2. France
      • 7.4.3.3. United Kingdom
      • 7.4.3.4. Spain
      • 7.4.3.5. Others
  • 7.5. Middle East and Africa
    • 7.5.1. By Type
    • 7.5.2. By Application
    • 7.5.3. By Country
      • 7.5.3.1. Saudi Arabia
      • 7.5.3.2. UAE
      • 7.5.3.3. Israel
      • 7.5.3.4. Others
  • 7.6. Asia Pacific
    • 7.6.1. By Type
    • 7.6.2. By Application
    • 7.6.3. By Country
      • 7.6.3.1. China
      • 7.6.3.2. India
      • 7.6.3.3. Japan
      • 7.6.3.4. South Korea
      • 7.6.3.5. Indonesia
      • 7.6.3.6. Thailand
      • 7.6.3.7. Others

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 8.1. Major Players and Strategy Analysis
  • 8.2. Market Share Analysis
  • 8.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 8.4. Competitive Dashboard

9. COMPANY PROFILES

  • 9.1. Abbott Laboratories
  • 9.2. bioMerieux SA
  • 9.3. Danaher Corporation
  • 9.4. Radiometer Medical ApS
  • 9.5. Trivitron Healthcare
  • 9.6. Siemens Healthcare GmbH
  • 9.7. Becton Dickinson Company
  • 9.8. Bayer AG
  • 9.9. Roche Diagnostics
  • 9.10. Bio-Rad Laboratories, Inc.

10. APPENDIX

  • 10.1. Currency
  • 10.2. Assumptions
  • 10.3. Base and Forecast Years Timeline
  • 10.4. Key Benefits for the Stakeholders
  • 10.5. Research Methodology
  • 10.6. Abbreviations